These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 26602203)

  • 21. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction.
    Tanner MA; Galanello R; Dessi C; Smith GC; Westwood MA; Agus A; Pibiri M; Nair SV; Walker JM; Pennell DJ
    J Cardiovasc Magn Reson; 2008 Feb; 10(1):12. PubMed ID: 18298856
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glutathione S-transferase gene polymorphism: Relation to cardiac iron overload in Egyptian patients with Beta Thalassemia Major.
    Mokhtar GM; Sherif EM; Habeeb NM; Abdelmaksoud AA; El-Ghoroury EA; Ibrahim AS; Hamed EM
    Hematology; 2016 Jan; 21(1):46-53. PubMed ID: 26288192
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Simultaneous Mapping of T
    Hamilton JI; Pahwa S; Adedigba J; Frankel S; O'Connor G; Thomas R; Walker JR; Killinc O; Lo WC; Batesole J; Margevicius S; Griswold M; Rajagopalan S; Gulani V; Seiberlich N
    J Magn Reson Imaging; 2020 Oct; 52(4):1044-1052. PubMed ID: 32222092
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reproducibility of area at risk assessment in acute myocardial infarction by T1- and T2-mapping sequences in cardiac magnetic resonance imaging in comparison to Tc99m-sestamibi SPECT.
    Langhans B; Nadjiri J; Jähnichen C; Kastrati A; Martinoff S; Hadamitzky M
    Int J Cardiovasc Imaging; 2014 Oct; 30(7):1357-63. PubMed ID: 24984612
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicenter validation of the magnetic resonance T2* technique for quantification of pancreatic iron.
    Meloni A; De Marchi D; Pistoia L; Grassedonio E; Peritore G; Preziosi P; Restaino G; Righi R; Riva A; Renne S; Schicchi N; Vallone A; Peluso A; Gerardi C; Positano V; Pepe A
    Eur Radiol; 2019 May; 29(5):2246-2252. PubMed ID: 30338366
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical feasibility of 3D-QALAS - Single breath-hold 3D myocardial T1- and T2-mapping.
    Kvernby S; Warntjes M; Engvall J; Carlhäll CJ; Ebbers T
    Magn Reson Imaging; 2017 May; 38():13-20. PubMed ID: 27998745
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of T1 mapping as a complementary tool to T2* for non-invasive cardiac iron overload assessment.
    Torlasco C; Cassinerio E; Roghi A; Faini A; Capecchi M; Abdel-Gadir A; Giannattasio C; Parati G; Moon JC; Cappellini MD; Pedrotti P
    PLoS One; 2018; 13(2):e0192890. PubMed ID: 29466447
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial T
    Liu Y; Hamilton J; Eck B; Griswold M; Seiberlich N
    Magn Reson Med; 2021 Jan; 85(1):103-119. PubMed ID: 32720408
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of myocardial T1 and T2 values in 3 T with T2* in 1.5 T in patients with iron overload and controls.
    Camargo GC; Rothstein T; Junqueira FP; Fernandes E; Greiser A; Strecker R; Pessoa V; Lima RS; Gottlieb I
    Int J Hematol; 2016 May; 103(5):530-6. PubMed ID: 26872908
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vivo comparison of myocardial T1 with T2 and T2* in thalassaemia major.
    Feng Y; He T; Carpenter JP; Jabbour A; Alam MH; Gatehouse PD; Greiser A; Messroghli D; Firmin DN; Pennell DJ
    J Magn Reson Imaging; 2013 Sep; 38(3):588-93. PubMed ID: 23371802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Importance of Cardiac T2* Magnetic Resonance Imaging for Monitoring Cardiac Siderosis in Thalassemia Major Patients.
    Chaosuwannakit N; Makarawate P; Wanitpongpun C
    Tomography; 2021 Apr; 7(2):130-138. PubMed ID: 33919601
    [No Abstract]   [Full Text] [Related]  

  • 32. Assessment of Cardiac Iron Overload in Thalassemia With MRI on 3.0-T: High-Field T1, T2, and T2* Quantitative Parametric Mapping in Comparison to T2* on 1.5-T.
    Krittayaphong R; Zhang S; Saiviroonporn P; Viprakasit V; Tanapibunpon P; Rerkudom B; Yindeengam A; Wood JC
    JACC Cardiovasc Imaging; 2019 Apr; 12(4):752-754. PubMed ID: 30448128
    [No Abstract]   [Full Text] [Related]  

  • 33. Myocardial T1 values in healthy volunteers measured with saturation method using adaptive recovery times for T1 mapping (SMART1Map) at 1.5 T and 3 T.
    Matsumoto S; Okuda S; Yamada Y; Suzuki T; Tanimoto A; Nozaki A; Jinzaki M
    Heart Vessels; 2019 Nov; 34(11):1889-1894. PubMed ID: 30976924
    [TBL] [Abstract][Full Text] [Related]  

  • 34. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
    Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
    Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. T1 mapping and T2 mapping at 3T for quantifying the area-at-risk in reperfused STEMI patients.
    Bulluck H; White SK; Rosmini S; Bhuva A; Treibel TA; Fontana M; Abdel-Gadir A; Herrey A; Manisty C; Wan SM; Groves A; Menezes L; Moon JC; Hausenloy DJ
    J Cardiovasc Magn Reson; 2015 Aug; 17(1):73. PubMed ID: 26264813
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Myocardial T2* Imaging at 3T and 1.5T: A Pilot Study with Phantom and Normal Myocardium.
    Chang S; Park J; Yang YJ; Beck KS; Kim PK; Choi BW; Jung JI
    J Cardiovasc Dev Dis; 2022 Aug; 9(8):. PubMed ID: 36005435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial T1 and T2 mapping at 3 T: reference values, influencing factors and implications.
    von Knobelsdorff-Brenkenhoff F; Prothmann M; Dieringer MA; Wassmuth R; Greiser A; Schwenke C; Niendorf T; Schulz-Menger J
    J Cardiovasc Magn Reson; 2013 Jun; 15(1):53. PubMed ID: 23777327
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cardiovascular magnetic resonance in heart transplant patients: diagnostic value of quantitative tissue markers: T2 mapping and extracellular volume fraction, for acute rejection diagnosis.
    Vermes E; Pantaléon C; Auvet A; Cazeneuve N; Machet MC; Delhommais A; Bourguignon T; Aupart M; Brunereau L
    J Cardiovasc Magn Reson; 2018 Aug; 20(1):59. PubMed ID: 30153847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Native T
    van den Boomen M; Slart RHJA; Hulleman EV; Dierckx RAJO; Velthuis BK; van der Harst P; Sosnovik DE; Borra RJH; Prakken NHJ
    J Magn Reson Imaging; 2018 Apr; 47(4):891-912. PubMed ID: 29131444
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Normal variation of magnetic resonance T1 relaxation times in the human population at 1.5 T using ShMOLLI.
    Piechnik SK; Ferreira VM; Lewandowski AJ; Ntusi NA; Banerjee R; Holloway C; Hofman MB; Sado DM; Maestrini V; White SK; Lazdam M; Karamitsos T; Moon JC; Neubauer S; Leeson P; Robson MD
    J Cardiovasc Magn Reson; 2013 Jan; 15(1):13. PubMed ID: 23331520
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.